Biomarkers at CENTOGENE - Individualize your patient's therapy

Title: Specific biomarkers for lysosomal storage disorders: enabling diagnosis, prediction and therapy monitoring


Interested in the latest innovations in metabolic disease diagnostics and assessing the effects of therapy? Do you want to learn more about biochemical genetic testing at CENTOGENE? Join this webinar to learn more about novel biomarkers for lysosomal storage disorders (LSDs).



An ideal biomarker plays an essential role in the early diagnosis, prediction and therapeutic monitoring of a specific disorder. Using a biomarker either as a diagnosis tool for lysosomal storage and other metabolic diseases, or in regular monitoring of the disease progression, can be of high clinical value for the patients. Biomarkers can be used as a measure of therapy efficacy and even as a guide for therapy dosage.

Would you like to find out more about CENTOGENE’s broad Biochemistry portfolio, including numerous enzymatic and biomarker analyses? Register now!


Webinar content:

• Introduction to Biomarker development and analysis at CENTOGENE

• Methodology/technology in CENTOGENE Biochemistry/Biomarker development

• Comprehensive clinical reporting

свернуть